Antiamoebic
Drugs
Faraza Javed
Mphil Pharmacology
AMEBIASIS
Amebiasis (also called amebic dysentry) is
an infection of intestinal tract caused by
Entamoeba histolytica. The disease can be
acute or chronic, with the patients
showing varying degrees of illness, from
no symptoms to mild diarrhea to
fulminating dysentery (Dysentery in which
the symptoms are intensely acute, leading to
prostration, collapse, and often death).
The diagnosis is established by
isolating E. histolytica from fresh
feces.
Therapy is aimed not only at the
acutely ill patients but also at those
who are asymptomatic carriers,
because dormant E. histolytica may
cause future infections in the carrier
and be a potential source of infections
for others.
Protozoal infections are common
among the people in underdeveloped
topical and subtropical
countries, where sanitary
conditions, hygienic practices and
control of vectors of transmission are
inadequate.
Life cycle of
Entamoeba histolytica
Entamoeba histolytica exists in two forms:
1. Cysts form (That can survive out side the
body).
2. Trophozoites form (That are labile and don’t
persist outside the body).
Life cycle
Life cycle consists of following steps:
1. Ingestion of cysts
Cysts are ingested through feces, contaminated food or
water.
2. Formation of trophozoites
Cysts are passed into the lumen of intestine, where the
trophozoites are liberated.
3. Penetration and multiplication of trophozoites
Trophozoites are penetrated in intestinal wall and
multiply within colon wall. They either invade and
ulcerate the mucosa of large intestine or simply feed
on intestinal bacteria.
4. Systemic invasion
Large numbers of trophozoites within the
colon wall can also lead to systemic
invasion and caused liver abscess.
5. Cysts discarded
The trophozoites within the intestine are
slowly carried toward the rectum, where
they return to cyst form and are excreted
in feces.
Classification of amebicidal
drugs
According to the site where the drug is effective,
the amebicidal drugs are classified as:
• Luminal amebicides (Act on parasite in the
lumen of bowel)
• Systemic amebicides (Against amebas in
intestinal wall & liver)
• Mixed amebicides ( Against both the luminal
and systemic form of diseases).
MIXED AMEBICIDES
1. Metronidazole (Flagyl)
• Mixed amebicides are used for the
treatment of amebic infections; it kills
the E. histolytica trophozoits.
• Extensively used in the treatment of
infections caused by Giardia lamblia,
Trichomonas vaginalis, Anaerobic cocci,
and Anaerobic gram negative bacilli.
• Drug of choice for the treatment of
pseudomembranous colitis caused by the
anaerobic, gram positive bacillus
Clostridium difficile.
• Activated by anaerobic organisms to a
compound that damage parasite DNA.
Mechanism of action of
Metronidazole
Metronidazole is a prodrug. It requires
reductive activation of nitro group by
susceptible organism. Its selective toxicity
towards anaerobic and microaerophilic
pathogens such as E. histolytica, G. lamblia,
etc. These organisms contain electron transport
components such as ferridoxin, small Fe-S
proteins that have sufficiently negative redox
potential to donate electrons to metronidazole.
The single electron transfer forms a
highly reactive nitro radical anion
that kills susceptible organisms by
radical-mediated mechanisms that
target DNA, resulting in cell death.
Mechanism of action of
Metronidazole
Pharmacokinetics
Absorption
Metronidazole is usually given orally and it is
rapidly and completely absorbed achieving
peak plasma concentration in 1-3 hours, with
half life of about 7 hours.
Distribution
It is distributed rapidly throughout the tissues,
reaching high concentration in the body fluids,
including cerebrospinal fluid.
Metabolism
Metabolism of metronidazole occurs in liver.
Excretion
The parent drug and its metabolites are
excreted in the urine.
Contraindication:
Phenobarbital is the inducer of this enzymatic
system so it enhances the rate of metabolism
when used concomitantly. Cimetidine inhibit
this system so it prolongs the plasma half life
of metronidazole.
Adverse effects:
An unpleasant metallic taste is often
experienced. The most common
adverse effects are those associated
with the gastrointestinal tract,
including nausea, vomiting, epigastric
distress, and abdominal cramps.
Urine:-dark/reddish-brown.
Tinidazole:
Tinidazole is a second-generation
nitroimidazole that is similar to
metronidazole in spectrum of
activity, absorption, adverse effects and
drug interactions. It was approved by the
U.S. Food and Drug Administration in
2004 for the treatment of amebiasis, amebic
liver abcess,
giardiasis and trichomoniasis but was used
outside the United States for decades prior
to approval. Tinidazole is as effective as
metronidazole, with a shorter course of
treatment, yet is more expensive than
generic metronidazole.
Iodoquinol
 Iodoquinol, a halogenated 8- hydroxy
quinolone.
 It is effective against Entamoeba histolytica,
luminal trophozite and cyst form.
 Side effects include rashes, diarrhea, dose-
related neuropathy, including rare optic
neuritis.
Long term use of drug should be avoided.
Paromomycin
 Aminoglycosides antiamebicides; alternative
agent for cryptosporidiosis.
 Not significantly absorbed from GIT, so
effective against the intestinal (luminal)
form of E. histolytica and tapeworm.
 Excreted in urine.
 Its antiamebic action is due to effect on cell
membranes, causing leakage and by
reducing the population of intestinal flora.
 Adverse effects:
 Gastrointestinal distress
 Diarrhea
SYSTEMIC AMEBICIDES
These drugs are useful in treating liver
abscesses or intestinal wall infections
caused by amebas.
Chloroquine:
 Used in combination with metronidazole
and diloxanide furoate to treat and
prevent amebic liver abscesses. It
eliminates trophozoites in liver abscesses.
 Also effective in treatment of malaria.
Emetine and Dehydroemetine:
Used as alternative agents for the treatment
of amebiasis.
 These inhibit protein synthesis by
blocking chain elongation.
 Intramuscular injection is the preferred
route.
 Emetine is concentrated in liver, where it
persists for a month after single dose.
 It is slowly metabolized and excreted,
and it can accumulate.
 Its half life in plasma is 5 days.
 The use of these, are limited by their
toxicities and close clinical observations
is necessary when these drugs are
administered.
 They should not be taken for more than 5
days.
 Dehydroemetine is only available under a
compassionate investigational new drug
protocol through the Centers of disease
Control and Prevention.
 The untoward effects are pain at the site
of infection, transient nausea,
cardiotoxicity, neuromuscular weakness,
dizziness, and rashes.
Antiamoebic drugs
Antiamoebic drugs

Antiamoebic drugs

  • 1.
  • 2.
    AMEBIASIS Amebiasis (also calledamebic dysentry) is an infection of intestinal tract caused by Entamoeba histolytica. The disease can be acute or chronic, with the patients showing varying degrees of illness, from no symptoms to mild diarrhea to fulminating dysentery (Dysentery in which the symptoms are intensely acute, leading to prostration, collapse, and often death).
  • 3.
    The diagnosis isestablished by isolating E. histolytica from fresh feces. Therapy is aimed not only at the acutely ill patients but also at those who are asymptomatic carriers, because dormant E. histolytica may cause future infections in the carrier and be a potential source of infections for others.
  • 4.
    Protozoal infections arecommon among the people in underdeveloped topical and subtropical countries, where sanitary conditions, hygienic practices and control of vectors of transmission are inadequate.
  • 5.
    Life cycle of Entamoebahistolytica Entamoeba histolytica exists in two forms: 1. Cysts form (That can survive out side the body). 2. Trophozoites form (That are labile and don’t persist outside the body). Life cycle Life cycle consists of following steps:
  • 6.
    1. Ingestion ofcysts Cysts are ingested through feces, contaminated food or water. 2. Formation of trophozoites Cysts are passed into the lumen of intestine, where the trophozoites are liberated. 3. Penetration and multiplication of trophozoites Trophozoites are penetrated in intestinal wall and multiply within colon wall. They either invade and ulcerate the mucosa of large intestine or simply feed on intestinal bacteria.
  • 7.
    4. Systemic invasion Largenumbers of trophozoites within the colon wall can also lead to systemic invasion and caused liver abscess. 5. Cysts discarded The trophozoites within the intestine are slowly carried toward the rectum, where they return to cyst form and are excreted in feces.
  • 9.
    Classification of amebicidal drugs Accordingto the site where the drug is effective, the amebicidal drugs are classified as: • Luminal amebicides (Act on parasite in the lumen of bowel) • Systemic amebicides (Against amebas in intestinal wall & liver) • Mixed amebicides ( Against both the luminal and systemic form of diseases).
  • 10.
    MIXED AMEBICIDES 1. Metronidazole(Flagyl) • Mixed amebicides are used for the treatment of amebic infections; it kills the E. histolytica trophozoits. • Extensively used in the treatment of infections caused by Giardia lamblia, Trichomonas vaginalis, Anaerobic cocci, and Anaerobic gram negative bacilli.
  • 11.
    • Drug ofchoice for the treatment of pseudomembranous colitis caused by the anaerobic, gram positive bacillus Clostridium difficile. • Activated by anaerobic organisms to a compound that damage parasite DNA.
  • 12.
    Mechanism of actionof Metronidazole Metronidazole is a prodrug. It requires reductive activation of nitro group by susceptible organism. Its selective toxicity towards anaerobic and microaerophilic pathogens such as E. histolytica, G. lamblia, etc. These organisms contain electron transport components such as ferridoxin, small Fe-S proteins that have sufficiently negative redox potential to donate electrons to metronidazole.
  • 13.
    The single electrontransfer forms a highly reactive nitro radical anion that kills susceptible organisms by radical-mediated mechanisms that target DNA, resulting in cell death.
  • 14.
    Mechanism of actionof Metronidazole
  • 15.
    Pharmacokinetics Absorption Metronidazole is usuallygiven orally and it is rapidly and completely absorbed achieving peak plasma concentration in 1-3 hours, with half life of about 7 hours. Distribution It is distributed rapidly throughout the tissues, reaching high concentration in the body fluids, including cerebrospinal fluid.
  • 16.
    Metabolism Metabolism of metronidazoleoccurs in liver. Excretion The parent drug and its metabolites are excreted in the urine. Contraindication: Phenobarbital is the inducer of this enzymatic system so it enhances the rate of metabolism when used concomitantly. Cimetidine inhibit this system so it prolongs the plasma half life of metronidazole.
  • 17.
    Adverse effects: An unpleasantmetallic taste is often experienced. The most common adverse effects are those associated with the gastrointestinal tract, including nausea, vomiting, epigastric distress, and abdominal cramps. Urine:-dark/reddish-brown.
  • 18.
    Tinidazole: Tinidazole is asecond-generation nitroimidazole that is similar to metronidazole in spectrum of activity, absorption, adverse effects and drug interactions. It was approved by the U.S. Food and Drug Administration in 2004 for the treatment of amebiasis, amebic liver abcess,
  • 19.
    giardiasis and trichomoniasisbut was used outside the United States for decades prior to approval. Tinidazole is as effective as metronidazole, with a shorter course of treatment, yet is more expensive than generic metronidazole.
  • 20.
    Iodoquinol  Iodoquinol, ahalogenated 8- hydroxy quinolone.  It is effective against Entamoeba histolytica, luminal trophozite and cyst form.  Side effects include rashes, diarrhea, dose- related neuropathy, including rare optic neuritis. Long term use of drug should be avoided.
  • 21.
    Paromomycin  Aminoglycosides antiamebicides;alternative agent for cryptosporidiosis.  Not significantly absorbed from GIT, so effective against the intestinal (luminal) form of E. histolytica and tapeworm.  Excreted in urine.  Its antiamebic action is due to effect on cell membranes, causing leakage and by reducing the population of intestinal flora.
  • 22.
     Adverse effects: Gastrointestinal distress  Diarrhea
  • 23.
    SYSTEMIC AMEBICIDES These drugsare useful in treating liver abscesses or intestinal wall infections caused by amebas. Chloroquine:  Used in combination with metronidazole and diloxanide furoate to treat and prevent amebic liver abscesses. It eliminates trophozoites in liver abscesses.  Also effective in treatment of malaria.
  • 24.
    Emetine and Dehydroemetine: Usedas alternative agents for the treatment of amebiasis.  These inhibit protein synthesis by blocking chain elongation.  Intramuscular injection is the preferred route.  Emetine is concentrated in liver, where it persists for a month after single dose.
  • 25.
     It isslowly metabolized and excreted, and it can accumulate.  Its half life in plasma is 5 days.  The use of these, are limited by their toxicities and close clinical observations is necessary when these drugs are administered.  They should not be taken for more than 5 days.
  • 26.
     Dehydroemetine isonly available under a compassionate investigational new drug protocol through the Centers of disease Control and Prevention.  The untoward effects are pain at the site of infection, transient nausea, cardiotoxicity, neuromuscular weakness, dizziness, and rashes.